Notice how her job title is gradually growing in status?
Bec's official appointment was COO, then in an early interview it became cheerfully referred to as "soon-to-be CEO" and now its COO / acting CEO.
Haha... forget the "acting" and just appoint her the CEO for god's sake!!!
Its like she has been employed as the CEO (doing the job of a CEO) but on trial - with trainer-wheels strapped to her. From what we have seen of her so far, she is doing a far better job than half the CEOs that head most of the speccie resource companies and done it for decades.
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-16
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.776M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.73K | 1.077M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 5624045 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 3249484 | 8 |
View Market Depth
| Last trade - 14.35pm 01/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |